NorthWest Biotherapeutics Inc (NWBO): Citadel Securities' balance sheet amount... (2024)

Citadel Securities' balance sheet amount of stock sold but not yet purchased, as of March 31, 2023, is $45.7 billion. This is known as "securities sold, not yet purchased" and represents obligations of Citadel Securities' subsidiaries to purchase the specified financial instrument at the then current market price.

This amount can fluctuate daily depending on the volume of trading activity and the market prices of the securities that Citadel Securities has sold but not yet purchased. However, it is generally a significant liability for the company, as it represents a potential obligation to deliver securities that Citadel Securities does not currently own.

It is important to note that Citadel Securities is a market maker, which means that it facilitates trades between buyers and sellers of securities. As such, it is common for Citadel Securities to have a significant amount of securities sold, not yet purchased, on its balance sheet. This is because Citadel Securities often buys and sells securities in order to maintain a liquid market and to provide liquidity to its customers.

However, the high amount of securities sold, not yet purchased, on Citadel Securities' balance sheet has raised concerns about the company's financial stability. Some critics argue that the company is too leveraged and that it is at risk of a margin call if the market prices of the securities that it has sold decline sharply.

Citadel Securities has defended its business practices and has stated that it has adequate resources to meet its obligations. However, the company's high level of securities sold, not yet purchased, remains a concern for some regulators and investors.

NorthWest Biotherapeutics Inc (NWBO): Citadel Securities' balance sheet amount... (2024)

FAQs

How many shares does NWBO have? ›

Northwest Biotherapeutics Shares Outstanding: 1.208B for May 6, 2024.

What are Eastern Bankshares total assets? ›

ABOUT EASTERN BANKSHARES, INC.

Founded in 1818, Boston-based Eastern Bank has more than 120 locations serving communities in eastern Massachusetts, southern and coastal New Hampshire, and Rhode Island. As of March 31, 2024, Eastern Bank had approximately $21 billion in total assets.

Who owns NWBO? ›

The ownership structure of Northwest Biotherapeutics (NWBO) stock is a mix of institutional, retail and individual investors. Approximately 0.06% of the company's stock is owned by Institutional Investors, 9.61% is owned by Insiders and 90.33% is owned by Public Companies and Individual Investors.

What is the future of NWBO stock? ›

NWBO Signals & Forecast

On further gains, the stock will meet resistance from the long-term Moving Average at $0.473. On a fall, the stock will find some support from the short-term average at $0.448.

How big is Western Alliance bank assets? ›

With more than $70 billion in assets, Western Alliance Bancorporation (NYSE: WAL) is one of the country's top-performing banking companies.

How big is bank of the West assets? ›

$ 91,580,361

How big is Pacwest bank assets? ›

Total assets on the balance sheet as of September 2023 : $36.87 B.

How many shares does Cummins have? ›

Cummins 2022 shares outstanding were 0.142B, a 2.47% decline from 2021. Cummins 2021 shares outstanding were 0.146B, a 2.08% decline from 2020.

How many shares does Brookfield Asset Management have? ›

According to Brookfield Asset Management's latest financial reports and stock price the company's current number of shares outstanding is 392,307,692. At the end of 2024 the company had 392,307,692 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

How many shares of stock does Bank of America have? ›

According to Bank of America 's latest financial reports and stock price the company's current number of shares outstanding is 7,968,200,000. At the end of 2024 the company had 7,968,200,000 shares outstanding.

How many employees does Northwest Biotherapeutics have? ›

Peer analysis
CompanyRevenue (TTM)Employees
Allogene Therapeutics Inc87.00k232.00
Cabaletta Bio Inc0.00118.00
SIGA Technologies Inc157.02m45.00
Northwest Biotherapeutics Inc1.34m25.00
8 more rows

Top Articles
Latest Posts
Article information

Author: Greg O'Connell

Last Updated:

Views: 5229

Rating: 4.1 / 5 (42 voted)

Reviews: 81% of readers found this page helpful

Author information

Name: Greg O'Connell

Birthday: 1992-01-10

Address: Suite 517 2436 Jefferey Pass, Shanitaside, UT 27519

Phone: +2614651609714

Job: Education Developer

Hobby: Cooking, Gambling, Pottery, Shooting, Baseball, Singing, Snowboarding

Introduction: My name is Greg O'Connell, I am a delightful, colorful, talented, kind, lively, modern, tender person who loves writing and wants to share my knowledge and understanding with you.